OTC · Drug Manufacturers - Specialty & Generic

Can B Corp. (CANB) Stock

$0.02 +16.18% OTC: CANB Healthcare

Can B Corp. operates within the United States, specializing in the development, manufacturing, and sale of products derived from cannabidiol (CBD).

Valuation

MetricValue
Price$0.02
Market Cap$1.49M
P/E Ratio-0.11
P/B Ratio-0.09
P/S Ratio0.00
EPS (TTM)$-0.17
52-Week High$0.18
52-Week Low$0.01
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE148.68%
ROA—
ROCE37.40%
Gross Margin0.00%
Operating Margin0.00%
Net Margin0.00%
Debt/Equity-0.65
Current Ratio0.02

Annual Financials (USD)

Metric20202021202220232024
Revenue$2.0M$5.0M$7.0M$2.0M$0
Operating Profit$-8.0M$-10.0M$-14.0M$-7.0M$-5.0M
Net Profit$-9.0M$-12.0M$-15.0M$-10.0M$-10.0M
EPS$-37.68$-9.06$-4.18$-0.77$-0.17
Op Margin-440.8%-223.0%-211.9%-347.3%—

Balance Sheet (USD)

Metric20202021202220232024
Total Assets$6.0M$16.0M$16.0M$10.0M$0
Total Liabilities$2.0M$11.0M$13.0M$11.0M$13.0M
Cash$0$0$0$0$0
Borrowings$2.0M$7.0M$9.0M$9.0M$8.0M

Latest News

Kirkland tops North America M&A table in H1 Private Banker International · Jul 30, 2026 Meta stock sinks 10% on earnings miss, 'barely passable' quarter Yahoo Finance · Jul 30, 2026 Morgan Stanley Says Amazon, Microsoft, and Google's AI Spending Will Pay Off Big GuruFocus.com · Jul 30, 2026 RBC Raises Price Target on General Dynamics to $410 From $385, Keeps Sector Perform Rating MT Newswires · Jul 30, 2026 Tourmaline Oil Q2 Earnings Fall 65% YoY MT Newswires · Jul 30, 2026

Cash Flow (USD)

Metric20202021202220232024
Operating Cash Flow$-2.0M$-7.0M$-4.0M$-1.0M$0
Investing Cash Flow$0$-2.0M$0$0$0
Financing Cash Flow$-1.0M$0$0$0$0
Net Cash Flow$0$0$0$0$0
Free Cash Flow$-2.0M$-8.0M$-4.0M$-1.0M$0

Valuation & Return Ratios

MetricValue
PEG Ratio0.00
EV / EBITDA-1.28
FCF Yield-14.83%
Quick Ratio0.02
Interest Coverage-2.68
Return 1Y—
Return 3Y—
Return 5Y—

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
ACNNFAusCann Group Holdings Ltd $0.00 — -1.63 $1.67M 0.00%
CBDNFCBD Global Sciences Inc. $0.04 -2.67% -0.20 $2.07M 0.00%
CIMVFPideka Group Inc. $0.01 +0.00% -1.16 $2.51M 0.00%
ETRGFEntourage Health Corp. $0.00 — -0.03 $1.23M 0.00%
IWINFIrwin Naturals Inc. $0.50 +51.52% -0.18 $1.68M 0.00%

About Can B Corp.

Can B Corp. operates within the United States, specializing in the development, manufacturing, and sale of products derived from cannabidiol (CBD). Its extensive range of hemp-based CBD offerings includes oils, topical creams, moisturizers, isolates, gel capsules, spa items, concentrates, and various lifestyle products. Customers can purchase these goods through the company's official website, automated vending machines, and via partnerships with medical professionals. The firm markets its products under distinct brand names such as Canbiola, Nu Wellness, Seven Chakras, and Pure Leaf Oil. The company, which changed its name from Canbiola Inc. to Can B Corp. in February 2020, was founded in 2005 and is headquartered in Hicksville, New York.

Can B Corp. is headquartered in US.

Can B Corp. (CANB) stock trades at $0.02 with a market capitalization of $1.49M. The stock is valued at a price-to-earnings (P/E) ratio of -0.11, price-to-book of -0.09, price-to-sales of 0.00. Over the past 52 weeks the stock has ranged between $0.01 and $0.18, and currently trades 88.9% below its 52-week high.

On profitability, Can B Corp. generates a return on equity (ROE) of 148.68% — well above the market average, a sign of a high-quality business, return on capital employed of 37.40%, an operating margin of 0.00%, a net profit margin of 0.00%.

Official website: canbcorp.com

Related Healthcare Stocks

LLY Drug Manufacturers - General $1185.71 -0.52% JNJ Drug Manufacturers - General $259.24 +0.88% ABBV Drug Manufacturers - General $246.04 +0.89% UNH Medical - Healthcare Plans $407.08 +0.77% MRK Drug Manufacturers - General $128.57 +0.16% NVS Drug Manufacturers - General $158.83 -0.64% NVO Biotechnology $51.58 +1.22% TMO Medical - Diagnostics & Research $594.00 +2.41% AMGN Drug Manufacturers - General $387.64 -1.39% ABT Medical - Devices $108.03 +0.70% GILD Drug Manufacturers - General $132.73 -1.18% PFE Drug Manufacturers - General $26.74 +2.06%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksAll stock screens
Run Stock Screener Investing Guides